Monday, April 3, 2017

Lets Grow OUR Medical Cannabis Community

New Mexico Medical Cannabis Community



The LECUA Medical Cannabis Community has provided the New Mexico Department of Health Medical Cannabis Program 20 Petitions for the Medical Cannabis Advisory Board to review and address at the MCAB Hearing 10am - Friday - April 7th - 2017.  New Mexico has been providing Medical Cannabis to patients in the State since 1978; It’s our goal for New Mexico to return as the leader of safe and accessible medical cannabis for all patients in the State and be a leader for this in the Southwest,  amongst the Top 3 Programs Nationally, and then be a Top 10 Medical Program World Wide.

10am - Friday - April 7th - 2017 - Meeting Location: Harold Runnels Building
1190 S. St. Francis Drive, Santa Fe, NM 87505
505-827-2613 Phone

Medical Cannabis Community Comments and Public Comments: Please take the time to look over the Petitions before the MCAB. We know how they MCP and medical cannabis is improving the quality of our lives, now let’s expand this to more and more New Mexicans. There are several ways your voice can be heard; attending the meeting for public comment, providing written comment at the meeting, in the mail, and email. Please also considering leaving comments on the website the Petitions are posted on.

Public meetings are a chance to articulate our message and show our strength to state officials,  elected officials, and the community at large...

Public comment period: The advisory board may provide for a public comment period. Public comment may be by written comment, verbal or both.
Written comment: Any individual or association of individuals may submit written comment to the advisory board either in opposition or support of the inclusion of a medical conditions, medical treatments or diseases to the existing list of debilitating medical conditions contained under the act. All written comment shall adhere to the requirements of Subsection F of this section.

Mailing Address
Department of Health
Medical Cannabis Program
PO Box 26110
Santa Fe, NM, 87502-6110
Email Address
medical.cannabis@state.nm.us

*Share Your Comments and Petitions you support or oppose with Your State Legislator & Invite Your State Legislator TO ATTEND The MCAB Hearing: Find My Legislator https://www.nmlegis.gov/Members/Find_My_Legislator



Read the Lynn And Erin Compassionate Use Act Here

Daily Lobo


Petitions Authored & Organized By Jason Barker
- Medical Cannabis Patient & Organizer with the
LECUA Patient’s Coalition Of New Mexico
Email Address
LECUAPatientsCoalitionNM@gmail.com



All Petitions Can Be Viewed Online At:
LECUA NM MCP MCAB Petitions
http://lecuanmmcpmcabpetitions.blogspot.com/

Petitions provided to the Medical Cannabis Advisory Board (MCAB)

  1. Petition Pertaining to the Medical Treatment; Adequate Supply: Limit of 230 Units per 3 months changed/increased
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

   II. Petition Pertaining to the Medical Treatment; Adequate Supply:
            Potency Cap of THC for  Concentrates Removed
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

   III. Petition Pertaining to the Medical Treatment; Adequate Supply:
            Personal Production License Plant Increase & PPL Collectives  
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*
   IV. Petition Pertaining to the Medical Treatment; Adequate Supply: LNPP Plant Count Increase
*(After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017. )* Informed of that via email on Fr. Mar. 31st 2017  *Interesting how a Petition is reviewed and denied (behind close doors) before being heard at the Public meeting…

   V. Petition Pertaining to the Medical Treatment; Adequate Supply:
            Remove CBD from Plant Count
*(After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017. )* Informed of that via email on Fr. Mar. 31st 2017  *Interesting how a Petition is reviewed and denied (behind close doors) before being heard at the Public meeting…

   VI. Petition Pertaining to the Condition to Add: Anxiety Disorder
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

   VII. Petition Pertaining to the Condition to Add: Autism Spectrum Disorder
*(After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017. )* Informed of that via email on Fr. Mar. 31st 2017  *Interesting how a Petition is reviewed and denied (behind close doors) before being heard at the Public meeting…

    VIII. Petition Pertaining to the Condition to Add: Concussion, CTE, & TBI
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

    IX. Petition Pertaining to the Condition to Add: Depression (clinical)
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

    X. Petition Pertaining to the Condition to Add: Diabetes Mellitus
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

    XI. Petition Pertaining to the Condition to Add: Dystonia
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*
    XII. Petition Pertaining to the Condition to Add: Migraine
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*
    XIII. Petition Pertaining to the Condition to Add: Rheumatoid Arthritis (RA) To Include:
There are more than 100 different forms of arthritis and related diseases. The most common types include osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthritis (PsA), fibromyalgia and gout.
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

    XIV. Petition Pertaining to the Condition to Add: Substance Abuse Disorder
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*
    XV. Petition Pertaining to the Medical Treatment; Exception To Qualifying Conditions To Add:
            A Person’s Status as a Veteran
*(After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017. )* Informed of that via email on Fr. Mar. 31st 2017  *Interesting how a Petition is reviewed and denied (behind close doors) before being heard at the Public meeting…

    XVI. Petition Pertaining to the Medical Treatment; Increase MCAB membership
            (Medical cannabis advisory board responsibilities and duties)
*(After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017. )* Informed of that via email on Fr. Mar. 31st 2017  *Interesting how a Petition is reviewed and denied (behind close doors) before being heard at the Public meeting…

   XVII. Petition Pertaining to the Medical Treatment; ADA language for Section 8 of LECUA
            (Medical cannabis registry identification cards)    
*(After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017. )* Informed of that via email on Fr. Mar. 31st 2017  *Interesting how a Petition is reviewed and denied (behind close doors) before being heard at the Public meeting…

  XVIII. Petition Pertaining to the Medical Treatment; Medical Cannabis 3 yr registry
            identification cards
Presumptive eligibility and once a patient is accepted into the program,  registry and PPL identification cards should be set at a 3 renewal basis. The Department can then do yearly address verification by mail all while maintaining safe access to medical cannabis.
*(After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017. )* Informed of that via email on Fr. Mar. 31st 2017  *Interesting how a Petition is reviewed and denied (behind close doors) before being heard at the Public meeting…

  XIX. Petition Pertaining to the Medical Treatment; Medical Cannabis Program Research
            & Education Established
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*

  XX. Petition Pertaining to the Condition to Add: Insomnia / Sleep Disorders
*Will Be Heard at the MCAB Hearing 10am - Friday - April 7th - 2017*




7.34.2.10 ADVISORY BOARD PUBLIC HEARING PROCEDURES:
               A.Public hearing requirement: The advisory board shall convene by public hearing at least twice per year to accept and review petitions requesting the inclusion of medical conditions, medical treatments or diseases to the list of debilitating medical conditions. Any meeting consisting of a quorum of the advisory board members held for the purpose of evaluating, discussing or otherwise formulating specific opinions concerning the recommendation of a petition filed pursuant to this rule, shall be declared a public hearing open to the public at all times, unless a portion of the hearing is closed to protect information made confidential by applicable state or federal laws.  A petitioner or his or her representative may request to close a portion of the hearing to protect the disclosure of confidential information by submitting their request in writing and having that request delivered to medical cannabis program staff at least 48 hours prior to the hearing.
               B. Location of the public hearing: Unless otherwise ordered by the advisory board, the public hearing shall be in held in New Mexico at a location sufficient to accommodate the anticipated audience.
               C.Public hearing notice: The medical cannabis program manager or designee shall, upon direction from the advisory board chairperson, prepare a notice of public hearing setting forth the date, time and location of the hearing, a brief description of the petitions received, and information on the requirements for public comment or statement of intent to present technical evidence, and no later than 30 days prior to the hearing date, send copies, with requests for publication, to at least one newspaper of general circulation.  The program manager or designee may further issue notice of the hearing by any other means the department determines to be acceptable to provide notice to the public.
               D.Public hearing agenda: The department shall make available an agenda containing a list of specific items to be discussed or information on how the public may obtain a copy of such agenda.
               E. Postponement of hearing: Request for postponement of a public hearing will be granted, by the advisory board for good cause shown.
               F. Statement of intent to present technical evidence: Any individual or association of individuals who wish to present technical evidence at the hearing shall, no later than 15 days prior to the date of the hearing, file a statement of intent. The statement of intent to present technical evidence shall include:
   (1) the name of the person filing the statement;
   (2)indication of whether the person filing the statement supports or opposes the petition at issue;
   (3) the name of each witness;
   (4) an estimate of the length of the direct testimony of each witness;
   (5) a list of exhibits, if any, to be offered into evidence at the hearing; and
   (6) a summary or outline of the anticipated direct testimony of each witness.
               G.Ex parte discussions: At no time after the initiation and before the conclusion of the petition process under this part, shall the department, or any other party, interested participant or their representatives discuss ex parte the merits of the petitions with any advisory board member.
               H.Public hearing process: The advisory board chairperson shall conduct the public hearing so as to provide a reasonable opportunity for all interested persons to be heard without making the hearing unreasonably lengthy or cumbersome or burdening the record with unnecessary repetition.
                            (1)A quorum of the advisory board shall consist of three voting members.
                            (2)The advisory board chairperson/ alternate shall convene each public hearing by:
                                               (a)           introduction of the advisory board members;
                                               (b)           statutory authority of the board;
                                               (c)           statement of the public hearing agenda; and
                                               (d)           recognition of the petitioner.
                               (3)Petitioner comment period. The petitioner or by representative may present evidence to the advisory board. The advisory board shall only consider findings of fact or scientific conclusions of medical evidence presented by the petitioner or by representative to the advisory board prior to or contemporaneously with the public hearing.
                               (4)Public comment period: The advisory board may provide for a public comment period. Public comment may be by written comment, verbal or both.
                                               (a) Written comment: Any individual or association of individuals may submit written comment to the advisory board either in opposition or support of the inclusion of a medical conditions, medical treatments or diseases to the existing list of debilitating medical conditions contained under the act. All written comment shall adhere to the requirements of Subsection F of this section.
Full text here: (http://164.64.110.239/nmac/parts/title07/07.034.0002.htm)




Appendix A: via Gmail
"Dear Mr. Barker,
After review and consideration the medical advisory board for the Medical Cannabis Program has decided your petition(s) either requires a legislative change or these petitions do not fall under the responsibilities of the Medical Advisory Board. As a result the petitions will not be heard at the Advisory Board meeting being held on April 07, 2017.
The following petitions will not be heard at the April 07, 2017 meeting:
Petition 2017-001 Petition to add being a veteran as a qualifying condition. Change to LECUA
Petition 2017-002 Change definition of debilitating medical condition in LECUA
Petition 2017-003 Change responsibilities of the Medical Advisory Board
Petition 2017-004 Change registration to be every three years, change in LECUA
Petition 2017-008 Remove CBD plants from producer plant count
Petition 2017-010 Increase LNPP plant count
Petition 2017-012 Add Autism as a condition"

*Informed of that via email on Fr. Mar. 31st -JB



BOYCOTT ULTRA HEALTH!

http://www.koat.com/news/medical-marijuana-grower-booted-from-state-fair/41588430

DO NOT SUPPORT ULTRA HEALTH WHO JEOPARDIZES THE MEDICAL CANNABIS PROGRAM & COMMUNITY BY RECKLESS ACTIONS OF SELF-PROMOTION!



Lynn & Erin Compassionate Use Act Patient’s Coalition of New Mexico ~ A GrassRoots Movement!
UNITE-NETWORK-GROW-INFORM-KNOW-EDUCATE-ACTIVISM-VOTE-HEALTH-WELLNESS
(All Rights Reserved 04/20/2016

No comments:

Post a Comment